Venus Medtech (Hangzhou) Inc. (stock code: 02500) has announced that its Board of Directors will convene on 31 March 2026. The meeting’s primary agenda is to review and approve the consolidated annual results for the financial year ended 31 December 2025, followed by the publication of the audited figures.
The session will also address any additional corporate matters deemed necessary. According to the disclosure, the company’s current board comprises three executive directors (Lim Hou-Sen, Liqiao Ma and Meirong Liu), two non-executive directors (Ao Zhang and Wei Wang) and three independent non-executive directors (Ting Yuk Anthony Wu, Chi Wai Suen and John Junhua Gu).
The announcement was authorised for issue by Executive Director Mr Lim Hou-Sen on 19 March 2026 in Hangzhou. No further financial details were provided ahead of the scheduled meeting.
Comments